Login / Signup

Impact of polyethylene glycol loxenatide on cardiovascular outcomes in patients with type 2 diabetes: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (BALANCE-3).

Yun XieJian KuangQuanmin LiTianpei HongLinong JiYuan Yuan KongYale DuanLiming Chen
Published in: BMJ open (2023)
ChiCTR2200056410.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • randomized controlled trial